December 2, 2025

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Navigating a 50% Potential Upside Amidst Market Volatility

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands out in the healthcare sector, particularly within the medical care facilities industry, as it continues to cater to the behavioral healthcare and recovery..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 43.52% Potential Upside in Biotech

Vericel Corporation (NASDAQ: VCEL), a notable player in the biotechnology sector, is capturing the interest of investors with its impressive potential for growth. With a current market capitalization of $1.96..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Strong Buy Ratings Signal Potential 25.69% Upside

Mirum Pharmaceuticals, Inc. (MIRM), a biopharmaceutical company headquartered in Foster City, California, is capturing the attention of investors with its promising portfolio and robust analyst endorsements. Specializing in the healthcare..

Addus HomeCare Corporation (ADUS) Stock Analysis: A Potential 17% Upside in the Healthcare Sector

Addus HomeCare Corporation (NASDAQ: ADUS) is drawing significant attention from investors within the healthcare sector, primarily due to its robust growth potential and promising analyst ratings. With a market capitalization..

Kymera Therapeutics (KYMR): Analyst Consensus Signals 16% Upside in Innovative Biotech Space

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a trailblazer in the biotechnology sector, is gaining attention from investors with its innovative approach to drug development. The company, headquartered in Watertown, Massachusetts, specializes..

Immunovant, Inc. (IMVT) Stock Analysis: Unpacking a 70% Upside Potential

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biotechnology company, is increasingly becoming a focal point for investors seeking opportunities in the healthcare sector. With a substantial market capitalization of $3.99 billion,..

Merus N.V. (MRUS) Stock Analysis: Navigating the Biotech Landscape with 1.10% Potential Upside

Merus N.V. (NASDAQ: MRUS), a prominent player in the biotechnology sector, is gaining attention in the investment community. With a current market capitalization of $7.28 billion, this Netherlands-based clinical-stage immuno-oncology..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Steady Performer in the Genomics Space with 51.9% Revenue Growth

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, continues to make notable strides in the genomics space. Based in..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Strong Revenue Growth and Analyst Confidence Signal Potential Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) stands out in the healthcare sector as a provider specializing in consumer-centric platforms for seniors, particularly through its Medicare Advantage plans. Based in Orange, California,..

QuidelOrtho Corporation (QDEL) Stock Analysis: A 42% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL) is making waves in the healthcare sector with a significant potential upside of 42.25%, according to analyst consensus. Specializing in diagnostic testing solutions, the company offers..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 32.61% Potential Upside in the Mental Health Sector

Investors with a keen interest in the healthcare sector might find LifeStance Health Group, Inc. (NASDAQ: LFST) a compelling prospect. Specializing in outpatient mental health services, LifeStance is positioning itself..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Assessing Its 1.78% Potential Upside and Promising Drug Pipeline

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) continues to capture investor attention with its innovative approach to tackling intractable diseases through RNA interference (RNAi) technology. With a robust pipeline and strategic partnerships,..

Amneal Pharmaceuticals (AMRX) Stock Analysis: Navigating Growth with a 9.67% Potential Upside

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a key player in the healthcare sector specializing in both generic and specialty drug manufacturing, presents an intriguing opportunity for investors seeking exposure to the..

Organon & Co. (OGN) Stock Analysis: Exploring a 27% Potential Upside Amidst a Volatile Market

Organon & Co. (OGN), a prominent player in the healthcare sector specializing in drug manufacturing, has captured investor attention with its diverse portfolio and strategic global presence. With a market..

Metsera, Inc. (MTSR) Investor Outlook: Navigating a 19.15% Potential Downside Amidst Biotech Innovations

Metsera, Inc. (MTSR), a clinical-stage biotechnology company based in New York, has garnered significant attention in the healthcare sector, particularly with its innovative approach to tackling obesity and related metabolic..

Zai Lab Limited (ZLAB) Investor Outlook: 148.93% Upside Potential in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biopharmaceutical landscape, is gaining attention from investors, particularly with its staggering potential upside of 148.93%. Based in China, Zai Lab..

Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a 17.97% Potential Upside Amidst Strong Revenue Growth

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector, especially within the medical instruments and supplies industry, continues to make waves in the eyewear market. With its..

Haemonetics Corporation (HAE) Stock Analysis: A Healthcare Play with a Solid Buy Consensus

For investors keen on the medical devices sector, Haemonetics Corporation (NYSE: HAE) presents a compelling opportunity. With a market capitalization of $3.9 billion, this Boston-based company is a recognized player..

Sotera Health Company (SHC) Stock Analysis: 9.10% Potential Upside Amid Robust Revenue Growth

Sotera Health Company (SHC), a prominent player in the healthcare sector, specializes in providing essential sterilization, lab testing, and advisory services across the United States and globally. With a current..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a Potential 55.9% Upside with Revolutionary Gene Editing Technology

As CRISPR Therapeutics AG (NASDAQ: CRSP) navigates the promising yet volatile waters of the biotechnology sector, individual investors are keenly eyeing its potential upside of 55.9%, anchored by a robust..

Search

Funds

December 2, 2025

Search

Funds

December 2, 2025

FTSE 100

Funds